Dr. Gregory T. Simonian, MD

Dr. Simonian practices at Bergen Surgical Specialists, PA in Hackensack, New Jersey.

Dr. Simonian's NPI, 1528017944, was assigned on May 10, 2006. Dr. Simonian graduated from Rutgers New Jersey Medical School in 1992. Dr. Simonian holds New Jersey license MA060740.

Dr. Simonian's primary practice is Bergen Surgical Specialists, PA, at 211 Essex St Suite 102 Suite 102, Hackensack, NJ 07601-3244. The practice phone is (201) 487-8882.

Dr. Simonian's primary practice is Bergen Surgical Specialists, PA in Hackensack, New Jersey. Dr. Simonian is also affiliated with Hackensack University Medical Center. The medical group on file is Bergen Surgical Specialists. Dmand AI also links Dr. Simonian to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Simonian practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Simonian's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Simonian is licensed in New Jersey.

CMS data shows 1,002 Medicare services from Dr. Simonian across 13 procedure codes in 2024, for 731 Medicare patients. Medicare paid $58,167 for them.

CMS counts 731 Medicare patients who saw Dr. Simonian in 2024. The largest group is 75 to 84, with 296 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Simonian's median patient age at 63, with 49% women.

In 2024, Dr. Simonian wrote 69 Medicare Part D claims for 15 patients. 59% of them were for generic drugs. CMS names the drug for 46 of them, across 3 drugs with 11 or more claims each, at $10,999 in total drug cost. In 2023, CMS named 36 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Simonian for performance year 2024, reported as part of a group. Dr. Simonian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Simonian, published from 2014 to 2025. 2020 was the busiest year, with 2. The most frequent topics are COVID-19 and SARS-CoV-2. Dr. Simonian has published most often in J Vasc Surg Venous Lymphat Disord. Dr. Simonian's most frequent co-authors are David J. O'Connor, MD, Massimo Mark Napolitano, MD and Michael Jeffrey Wilderman, MD.

Dmand AI links Dr. Simonian to 1 clinical trial. Conditions studied include Pulmonary Embolism and Embolism.

CMS Open Payments shows 70 general payments to Dr. Simonian from 26 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 38% of the total. Octapharma USA, Inc. paid the most, $6,197. It also lists 1 research payment totaling $4,000 in 2022.

Dr. Simonian graduated from Rutgers New Jersey Medical School in 1992.